Name: Cardiosolutions Inc.
Location: West Bridgewater, Massachusetts
From Blind Spots to Better Outcomes: How SNF Data Transparency Strengthens LTSS
What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.
Industry: Medical Devices
Products: Developing PerCu-Pro System that is an implanted device to percutaneously repair the mitral valve to prevent blood leaking into the left ventricle (also known as mitral valve regurgitation); the Dexterity Steerable Introducer is a flexible tool that allows physicians to reach difficult-to-access regions of the heart.
Money raised: $14.8 million (previous filings show that the company has raised at least $10.7 million in earlier rounds).
How it will be used: Company didn’t immediately return a call in response to that question.
Automation Didn’t Dehumanize Care. Bad Systems Did.
We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring.
Investors: BioVentures Investors.
Management team: Steven Tallarida, president and chairman; Jon Wilson, chief operating officer; Ross Garofalo, vice president and chief financial officer.
Market size: Several companies note that about 4 million Americans have leaky mitral heart valves.
Competitors: Edwards Lifesciences, QuantumCor, Mitralign, MiCardia among others
[Photo Credit: Flickr user amagill]